CVE-2021-41316

CVE-2021-41316 is a high-severity vulnerability in Device42 with a CVSS 3.x base score of 8.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-88.

Key facts

Description

The Device42 Main Appliance before 17.05.01 does not sanitize user input in its Nmap Discovery utility. An attacker (with permissions to add or edit jobs run by this utility) can inject an extra argument to overwrite arbitrary files as the root user on the Remote Collector.

Frequently asked questions

What is CVE-2021-41316?
The Device42 Main Appliance before 17.05.01 does not sanitize user input in its Nmap Discovery utility. An attacker (with permissions to add or edit jobs run by this utility) can inject an extra argument to overwrite arbitrary files as the root user on the Remote Collector.
How severe is CVE-2021-41316?
CVE-2021-41316 has a CVSS 3.x base score of 8.1, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability high.
Is CVE-2021-41316 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (69th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2021-41316?
CVE-2021-41316 affects Device42. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2021-41316?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2021-41316 published?
CVE-2021-41316 was published on 2021-09-17 and last updated on 2026-06-17.

References

Affected products (1)

Other CWE-88 (Argument Injection) vulnerabilities

Browse all CWE-88 (Argument Injection) vulnerabilities →